New drug combo may keep liver cancer at bay after transplant
NCT ID NCT02081755
First seen Jan 29, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This study looks at whether a drug called everolimus can help prevent liver cancer from coming back after a liver transplant. About 336 adults with high-risk liver cancer will receive either everolimus plus tacrolimus or standard drugs. The main goal is to see how long patients live without their cancer returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mount Sinai Medical Center
New York, New York, 10029, United States
-
Northwestern University School of Medicine
Chicago, Illinois, 60611, United States
-
University of California at San Francisco
San Francisco, California, 94143, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Tennessee- Methodist University Hospital
Memphis, Tennessee, 38104, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.